A COMPARISON OF 3 FLUOROPHORES FOR USE IN AN OPTICAL BIOSENSOR FOR THE MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN WHOLE-BLOOD

被引：17
|
作者：
DANIELS, PB
FLETCHER, JE
ONEILL, PM
STAFFORD, CG
BACARESEHAMILTON, T
ROBINSON, GA
机构：
[1] SCL Bioscience Services Ltd., Woking, Surrey GU21 5JY, 21 Woking Business Park, Albert Dr.
来源：
SENSORS AND ACTUATORS B-CHEMICAL | 1995年 / 27卷 / 1-3期
关键词：
ANTIGENS; FLUOROPHORES; OPTICAL IMMUNOSENSORS;
D O I：
10.1016/0925-4005(94)01637-W
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
In order to obtain maximum analytical performance from an optical immunosensor which uses whole blood as the sample matrix, rigorous selection of the fluorophore and the associated optical filtration is required. Three fluorophores, allophycocyanin (APC), carboxymethylindocyanine succinimidyl ester (C45) and fluorescein isothiocyanate (FITC), were evaluated in whole blood and serum assays using the fluorescence capillary fill device immunosensor. APC gave the best analytical performance. Whole-blood patient samples were assayed using APC as the label and an excellent correlation was obtained with a commercially available immunoassay.
引用
收藏
页码：447 / 451
页数：5
相关论文
共 50 条
  • [41] CAUSES FOR CONCERN IN THE USE OF PROSTATE-SPECIFIC ANTIGEN ASSAYS
    DENNIS, PM
    STRINGER, M
    SIKARIS, K
    MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (03) : 230 - 230
  • [42] Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder
    Aaronson, David S.
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 547 - 548
  • [43] Prostate-Specific Membrane Antigen Use in Glioma Management
    Mcbriar, Joshua D.
    Shafiian, Neeva
    Scharf, Stephen
    Boockvar, John A.
    Wernicke, A. Gabriella
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 806 - 816
  • [44] Urinary/serum prostate-specific antigen ratio:: Comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection
    Irani, J
    Salomon, L
    Soulié, M
    Zlotta, A
    de la Taille, A
    Doré, B
    Millet, C
    UROLOGY, 2005, 65 (03) : 533 - 537
  • [45] Comparison of prostate-specific antigen adjusted for transition zone volume versus prostate-specific antigen density in predicting prostate cancer by transrectal ultrasonography
    Sung, DJ
    Cho, SB
    Kim, YH
    Oh, YW
    Lee, NJ
    Kim, JH
    Chung, KB
    Moon, DG
    JOURNAL OF ULTRASOUND IN MEDICINE, 2004, 23 (05) : 615 - 622
  • [46] USE OF HUMAN PROSTATE-SPECIFIC ANTIGEN IN MONITORING PROSTATE-CANCER
    KURIYAMA, M
    WANG, MC
    LEE, CL
    PAPSIDERO, LD
    KILLIAN, CS
    INAJI, H
    SLACK, NH
    NISHIURA, T
    MURPHY, GP
    CHU, TM
    CANCER RESEARCH, 1981, 41 (10) : 3874 - 3876
  • [47] Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening Reply
    Miller, David C.
    Hollenbeck, Brent K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (13): : 1373 - 1374
  • [48] The use of prostate-specific antigen kinetics to stratify risk in prostate cancer
    Presti Jr. J.
    Current Urology Reports, 2008, 9 (3) : 226 - 230
  • [49] Measurement of prostate-specific membrane antigen in the serum with a new antibody
    Murphy, GP
    Tino, WT
    Holmes, EH
    Boynton, AL
    Erickson, SJ
    Bowes, VA
    Barren, RJ
    Tjoa, BA
    Misrock, SL
    Ragde, H
    Kenny, GM
    PROSTATE, 1996, 28 (04): : 266 - 271
  • [50] Comparison of an electrochemical biosensor with optical devices for hemoglobin measurement in human whole blood samples
    Hsieh, Ming-Song
    Wu, Tai-Guang
    Su, Chein-Shyong
    Cheng, Wen-Jing
    Ozbek, Namik
    Tsai, Kun-Yuan
    Lin, Ching-Yu
    CLINICA CHIMICA ACTA, 2011, 412 (23-24) : 2150 - 2156
12345